Nigeria recorded 216 fresh coronavirus (COVID-19) cases on Wednesday, the country’s health agency has said.
The Nigeria Centre for Disease Control (NCDC) also announced four deaths, bringing total infections in the country to 54, 463.
The NCDC made this known on its official twitter handle on Wednesday.
The health agency said that a multi-sectoral national Emergency Operations Centre (EOC), activated at Level 3 had continued to coordinate the national response activities across the country.
It disclosed that the new infections were recorded in 15 states including the Federal Capital Territory (FCT).
Out of the 216 new cases, Plateau has remained the state with the highest number at 59, followed by Rivers, Abia, and Lagos at 27, 22, and 20 respectively.
Others are Oyo – 18, Enugu – 17, Kaduna – 11, FCT – 11, Ogun – 10, Ebonyi – four, Osun – four, Ekiti – four, Delta – three, Edo – three, Akwa Ibom – two, and Bauchi – one.
The health agency said that this brings the total number of infections in the country since its first index case in February to 54,463.
It noted that those who had lost the their lives to the virus in country increased by four, raising the death toll of infections to 1,027.
The health agency also said that the number of recoveries in the country increased to 42,439 after 429 more patients were successfully treated and discharged from various isolation centres in the country.
It disclosed that on Monday, Nigeria recorded a total of 10,997, recoveries.
The NCDC stated that this represented 20.19 per cent of the total confirmed cases with 77.92 per cent recoveries and 1.88 per cent deaths recorded.
Meanwhile, the health agency noted that the success of the public health response to COVID-19 was not dependent only on the efforts at the national level.
It said it is also dependent on the actions of various communities and individuals to adapt the messages and solutions to their local context.
“One good thing from Nigeria’s polio experience is a well developed vaccine delivery mechanism.”
“What we now need to do is ensure we have the right data on the immunity levels of our population to guide decision making around prioritisation within our context,” it said.
